| Literature DB >> 25520712 |
Janessa Pickering1, Peter C Richmond2, Lea-Ann S Kirkham2.
Abstract
Non-typeable Haemophilus influenzae (NTHi) and Haemophilus haemolyticus are closely related bacteria that reside in the upper respiratory tract. NTHi is associated with respiratory tract infections that frequently result in antibiotic prescription whilst H. haemolyticus is rarely associated with disease. NTHi and H. haemolyticus can be indistinguishable by traditional culture methods and molecular differentiation has proven difficult. This current review chronologically summarizes the molecular approaches that have been developed for differentiation of NTHi from H. haemolyticus, highlighting the advantages and disadvantages of each target and/or technique. We also provide suggestions for the development of new tools that would be suitable for clinical and research laboratories.Entities:
Keywords: Haemophilus haemolyticus; NTHi; culture; identification; molecular differentiation
Year: 2014 PMID: 25520712 PMCID: PMC4251515 DOI: 10.3389/fmicb.2014.00664
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Summary of gene targets and methodologies used to discriminate .
| DNA seq, PCR | 114 (102 SP, 12 NP) | 318 (156 SP, 32 NP, 130 MEE) | Murphy et al., | Dendrogram of | |
| DNA seq | 7 (1 ref, 5 SP, 1 dental plaque) | 8 (1 PS, 1 SP, 1 UN, 1 CSF, 3 blood, 1 LS) | Norskov-Lauritsen et al., | ||
| PCR | 1 (LS) | 12 (LS) | Abdeldaim et al., | ||
| DNA seq | 7 (1 ref, 5 SP, 1 dental plaque) | 8 (1 PS, 1 SP, 1 UN, 1 CSF, 3 blood, 1 LS) | Norskov-Lauritsen, | Increased level of | |
| DNA seq | 44 (44 RT) | 78 (78 RT) | Theodore et al., | Six distinct phylogenetic groups observed | |
| PCR, DNA seq | 28 (27 NP, 1 reference) | 27 (21 NP, 6 refs) | Binks et al., | ||
| 11 equivocal (NP) | |||||
| seq of concatenated | 20 (PS-asymptomatic) | 52 (5 PS-asymptomatic, 47 PS-URTi) | Zhu et al., | ||
| FISH | 7 (1 ref, 2 SP, 1 BAL, 1 PS, 1 U, 1 GF) | 50 (8 SP, 9 NP, 8 TS, 4 BAL, 4 PS, 6 ES, 5 NS, 1 BS, 2 EARS, 1 MSS, 1 ref) | Frickmann et al., | ||
| PCR, Southern blot, Dot blot, IEF | 20 | 20 | Fung et al., | ||
| Hybridization blots | 1 (LS) | 480 (241 RT, 161 MEE, 68 CS, 10 from other sites-2 blood) | Norskov-Lauritsen, | 1.6% of | |
| Microarray, MLSA, IEF, Southern blot, DNA seq | 110 | 169 | McCrea et al., | ||
| DNA seq, Immuno-blot, 7F3 MAb | 6 | 12 | Murphy et al., | ||
| Immuno-blot | 109 (63 HT, 46 SP) | 88 (44 ME, 44 HT) | McCrea et al., | P6 detected ~97% of NTHi strains and ~12% of | |
| PCR | 1 (LS) | 12 (LS) | Abdeldaim et al., | ||
| PCR | 12 (oropharyngeal) | 151 (50 oropharyngeal, 50 nasopharyngeal, 51 MEE) | Chang et al., | P6 is not completely conserved in NTHi, and not all NTHi can be reliably distinguished from | |
| PCR HRM | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | ||
| 11 equivocal (11 NP) | |||||
| PCR | 1 (LS) | 12 (LS) | Abdeldaim et al., | ||
| PCR | 1 (LS) | 12 (LS) | Abdeldaim et al., | ||
| LOS genes | PCR, DNA hybridization, Southern and Western blot | 109 (63 HT, 46 SP) | 88 (44 MEE, 44 HT) | McCrea et al., | |
| PCR | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | ||
| 11 equivocal (11 NP) | |||||
| Micro-array, dot blot | 50 (HT, SP, micro-array) | 50 (HT, SP and ME, micro-array) | McCrea et al., | The | |
| 109 (HT, SP, dot blot) | 88 (HT, SP and ME, dot blot) | ||||
| IgA1 protease activity, DNA seq | 7 (1 ref, 5 SP, 1 dental plaque) | 8 (1 PS, 1 SP, 1 UN, 1 CSF, 3 blood, 1 LS) | Norskov-Lauritsen et al., | ||
| PCR | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | The | |
| 11 equivocal (11 NP) | |||||
| House-keeping genes | MLST | 7 (1 LS, 6 variants) | 90 (1 LS, 1 COPD, 88 MLST database) | Murphy et al., | Variant strains did not encode |
| MLST | 7 (1 ref, 5 SP, 1 dental plaque) | 8 (1 PS, 1 SP, 1 unknown origin, 1 CSF, 3 blood, 1 LS) | Norskov-Lauritsen et al., | ||
| DNA seq, PCR, Neighbor joining tree analysis, MLST | 1 (LS) | 627 (MLST database, 7 ref, 1 LS, 31 variants) | Ridderberg et al., | ||
| RTPCR | 17 (1 invasive sequencing), 16 carriage isolates (sens/spec calcs) | 247 (6 capsulate strains, 4 invasive NTHi (sequencing). 208 invasive, 29 carriage isolates (sens/spec calcs) | Wang et al., | ||
| RTPCR | 44 (44 PS carriage) | 78 (78 PS carriage) | Theodore et al., | 9 of 78 | |
| RTPCR | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | ||
| 11 equivocal (11 NP) | |||||
| HRM-PCR | 32 (1 ref, 31 NP) sequencing, 54 (NP, BAL, throat) HRM | 138 (NP, BAL, throat) for HRM | Pickering et al., | ||
| PCR | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | ||
| 11 equivocal (11 NP) | |||||
| DNA seq | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | ||
| 11 equivocal (11 NP) | |||||
| DNA seq of concatenated | 20 (PS-asymptomatic) | 52 (5 PS-asymptomatic, 47 PS from patients with URTI) | Zhu et al., | ||
| Hybridization blots | 1 (LS) | 480 (241 RS, 161 MEE, 68 CS, 10 from other sites-2 blood) | Norskov-Lauritsen, | ||
| Sequencing, PCR, Neighbor-joining tree analysis | 1 (LS) | 627 (MLST database, 7 ref, 1 LS, 31 variants) | Ridderberg et al., | Occasional isolates of | |
| PCR | 44 (44 PS carriage) | 78 (78 PS carriage) | Theodore et al., | 22/78 | |
| PCR | 28 (27 NP, 1 ref) | 27 (21 NP, 6 ref) | Binks et al., | ||
| 11 equivocal (11 NP) | |||||
| qPCR | 1 (LS) | 12 (LS) | Abdeldaim et al., | Specifically detects | |
| Hybridization blots | 1 (LS) | 480 (241 RS, 161 MEE, 68 CS, 10 from other sites-2 blood) | Norskov-Lauritsen, | ||
| Antibiotic resistance genes | RTPCR | 50 (URT) | 50 (URT) | Witherden et al., | Phenotypic and genotypic β-lactam resistance is present in NTHi and |
| Mass-spectrometry | MALDI-TOF MS (Bruker) | 20 (PS-asymptomatic) | 52 (5 PS-asymptomatic, 47 PS-URTi) | Zhu et al., | Extending the original reference database provided with the Bruker biotype software to include more strains enabled 100% detection of NTHi and |
| MALDI-TOF-MS (Bruker/Shimadzu) | 7 (1 ref, 2 SP, 1 BAL, 1 PS, 1 U, 1 GF) | 50 (8 SP, 9 NP, 8 TS, 4 BAL, 4 PS, 6 ES, 5 NS, 1 BS, 2 EARS, 1 MSS, 1 ref) | Frickmann et al., | The Bruker MALDI-TOF device outperformed the Shimadzu, but MALDI-TOF was not completely discriminatory for NTHi and | |
,unknown site of isolation;
, data not shown;
, unclear whether typeable or non-typeable H. influenzae strains were assessed.
BAL, bronchoalveolar lavage; BLNAR, β-lactam negative ampicillin resistant; BS, bronchial secretion; CS, conjunctival swab; CSF, cerebrospinal fluid; EARS, ear swab; ES, eye swab; FISH, fluorescent in situ hybridization; GS, gastric fluid; HT, healthy throat; HRM, high resolution melt; IEF, isoelectric field; LS, laboratory strain; MALDI-TOF MS, matrix assisted laser desorption ionization time of flight mass spectrometry; MEE, middle ear effusion; ME, middle ear; MLSA, multilocus sequence analysis; MLST, multilocus sequence typing; MSS, Maxillary sinus swab; NS, nasal secretion; NP, nasopharyngeal; PCR, polymerase chain reaction; PS, pharyngeal swab; qPCR, quantitative PCR; ref, reference strain; RT, respiratory tract; sens/spec calcs, sensitivity and specificity calculations; SDS PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; seq, sequencing; SP, sputum; TS, tracheal secretion; U, urine; URT, upper respiratory tract; URTi, URT infection; UN, unknown origin.